Citace podle APA (7th ed.)

Park, S. E., Park, K., Lee, E., Kim, J., Ahn, J. S., Im, Y., . . . Park, Y. H. (2018). Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer. Oncoimmunology, 7(8), e1466768. https://doi.org/10.1080/2162402X.2018.1466768

Citace podle Chicago (17th ed.)

Park, Song Ee, et al. "Clinical Implication of Tumor Mutational Burden in Patients with HER2-positive Refractory Metastatic Breast Cancer." Oncoimmunology 7, no. 8 (2018): e1466768. https://doi.org/10.1080/2162402X.2018.1466768.

Citace podle MLA (9th ed.)

Park, Song Ee, et al. "Clinical Implication of Tumor Mutational Burden in Patients with HER2-positive Refractory Metastatic Breast Cancer." Oncoimmunology, vol. 7, no. 8, 2018, p. e1466768, https://doi.org/10.1080/2162402X.2018.1466768.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..